CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands |
Total |
Follow-on Public Offering |
At The Market Equity Offering |
Common Stock |
Common Stock
Follow-on Public Offering
|
Common Stock
At The Market Equity Offering
|
Additional Paid-In Capital |
Additional Paid-In Capital
Follow-on Public Offering
|
Additional Paid-In Capital
At The Market Equity Offering
|
Accumulated Other Comprehensive Income/(Loss) |
Accumulated Deficit |
| Beginning balance at Dec. 31, 2024 |
$ 2,265,204
|
|
|
$ 18
|
|
|
$ 4,001,666
|
|
|
$ 1,321
|
$ (1,737,801)
|
| Beginning balance, shares at Dec. 31, 2024 |
|
|
|
185,896,625
|
|
|
|
|
|
|
|
| Issuance of common stock pursuant to stock option exercises |
891
|
|
|
|
|
|
891
|
|
|
|
|
| Issuance of common stock pursuant to stock option exercises, shares |
|
|
|
90,043
|
|
|
|
|
|
|
|
| Issuance of common stock related to vesting of restricted stock units, shares |
|
|
|
271,536
|
|
|
|
|
|
|
|
| Exercise of warrants |
1
|
|
|
|
|
|
1
|
|
|
|
|
| Exercise of warrants, shares |
|
|
|
2
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
25,084
|
|
|
|
|
|
25,084
|
|
|
|
|
| Net unrealized gain (loss) on marketable securities |
386
|
|
|
|
|
|
|
|
|
386
|
|
| Net Income (Loss) |
(213,416)
|
|
|
|
|
|
|
|
|
|
(213,416)
|
| Ending balance at Mar. 31, 2025 |
2,078,150
|
|
|
$ 18
|
|
|
4,027,642
|
|
|
1,707
|
(1,951,217)
|
| Ending balance, shares at Mar. 31, 2025 |
|
|
|
186,258,206
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
2,265,204
|
|
|
$ 18
|
|
|
4,001,666
|
|
|
1,321
|
(1,737,801)
|
| Beginning balance, shares at Dec. 31, 2024 |
|
|
|
185,896,625
|
|
|
|
|
|
|
|
| Net unrealized gain (loss) on marketable securities |
(19)
|
|
|
|
|
|
|
|
|
|
|
| Net Income (Loss) |
(461,203)
|
|
|
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
1,865,369
|
|
|
$ 18
|
|
|
4,063,053
|
|
|
1,302
|
(2,199,004)
|
| Ending balance, shares at Jun. 30, 2025 |
|
|
|
186,901,268
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
2,265,204
|
|
|
$ 18
|
|
|
4,001,666
|
|
|
1,321
|
(1,737,801)
|
| Beginning balance, shares at Dec. 31, 2024 |
|
|
|
185,896,625
|
|
|
|
|
|
|
|
| Ending balance at Dec. 31, 2025 |
1,631,297
|
|
|
$ 19
|
|
|
4,497,143
|
|
|
3,237
|
(2,869,102)
|
| Ending balance, shares at Dec. 31, 2025 |
|
|
|
197,001,401
|
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
2,078,150
|
|
|
$ 18
|
|
|
4,027,642
|
|
|
1,707
|
(1,951,217)
|
| Beginning balance, shares at Mar. 31, 2025 |
|
|
|
186,258,206
|
|
|
|
|
|
|
|
| Issuance of common stock pursuant to stock option exercises |
1,937
|
|
|
|
|
|
1,937
|
|
|
|
|
| Issuance of common stock pursuant to stock option exercises, shares |
|
|
|
121,103
|
|
|
|
|
|
|
|
| Issuance of common stock related to vesting of restricted stock units, shares |
|
|
|
361,975
|
|
|
|
|
|
|
|
| Issuance of common stock related to employee stock purchase plan |
4,644
|
|
|
|
|
|
4,644
|
|
|
|
|
| Issuance of common stock related to employee stock purchase plan, shares |
|
|
|
159,984
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
28,830
|
|
|
|
|
|
28,830
|
|
|
|
|
| Net unrealized gain (loss) on marketable securities |
(405)
|
|
|
|
|
|
|
|
|
(405)
|
|
| Net Income (Loss) |
(247,787)
|
|
|
|
|
|
|
|
|
|
(247,787)
|
| Ending balance at Jun. 30, 2025 |
1,865,369
|
|
|
$ 18
|
|
|
4,063,053
|
|
|
1,302
|
(2,199,004)
|
| Ending balance, shares at Jun. 30, 2025 |
|
|
|
186,901,268
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
1,631,297
|
|
|
$ 19
|
|
|
4,497,143
|
|
|
3,237
|
(2,869,102)
|
| Beginning balance, shares at Dec. 31, 2025 |
|
|
|
197,001,401
|
|
|
|
|
|
|
|
| Issuance of common stock pursuant to stock option exercises |
12,209
|
|
|
|
|
|
12,209
|
|
|
|
|
| Issuance of common stock pursuant to stock option exercises, shares |
|
|
|
473,472
|
|
|
|
|
|
|
|
| Issuance of common stock related to vesting of restricted stock units, shares |
|
|
|
367,871
|
|
|
|
|
|
|
|
| Issuance of common stock, net of offering costs |
|
|
$ 226,730
|
|
|
|
|
|
$ 226,730
|
|
|
| Issuance of common stock upon offering, net of offering costs, shares |
|
|
|
|
|
2,335,397
|
|
|
|
|
|
| Exercise of warrants |
57
|
|
|
|
|
|
57
|
|
|
|
|
| Exercise of warrants, shares |
|
|
|
485
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
87,299
|
|
|
|
|
|
87,299
|
|
|
|
|
| Foreign currency translation adjustment |
(8)
|
|
|
|
|
|
|
|
|
(8)
|
|
| Net unrealized gain (loss) on marketable securities |
(3,851)
|
|
|
|
|
|
|
|
|
(3,851)
|
|
| Net Income (Loss) |
(453,816)
|
|
|
|
|
|
|
|
|
|
(453,816)
|
| Ending balance at Mar. 31, 2026 |
1,499,917
|
|
|
$ 19
|
|
|
4,823,438
|
|
|
(622)
|
(3,322,918)
|
| Ending balance, shares at Mar. 31, 2026 |
|
|
|
200,178,626
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
1,631,297
|
|
|
$ 19
|
|
|
4,497,143
|
|
|
3,237
|
(2,869,102)
|
| Beginning balance, shares at Dec. 31, 2025 |
|
|
|
197,001,401
|
|
|
|
|
|
|
|
| Net unrealized gain (loss) on marketable securities |
(9,086)
|
|
|
|
|
|
|
|
|
|
|
| Net Income (Loss) |
(1,098,187)
|
|
|
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
2,606,238
|
|
|
$ 21
|
|
|
6,579,456
|
|
|
(5,950)
|
(3,967,289)
|
| Ending balance, shares at Jun. 30, 2026 |
|
|
|
214,242,688
|
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2026 |
1,499,917
|
|
|
$ 19
|
|
|
4,823,438
|
|
|
(622)
|
(3,322,918)
|
| Beginning balance, shares at Mar. 31, 2026 |
|
|
|
200,178,626
|
|
|
|
|
|
|
|
| Issuance of common stock pursuant to stock option exercises |
28,844
|
|
|
$ 1
|
|
|
28,843
|
|
|
|
|
| Issuance of common stock pursuant to stock option exercises, shares |
|
|
|
1,309,927
|
|
|
|
|
|
|
|
| Issuance of common stock related to vesting of restricted stock units, shares |
|
|
|
395,886
|
|
|
|
|
|
|
|
| Issuance of common stock related to employee stock purchase plan |
8,473
|
|
|
|
|
|
8,473
|
|
|
|
|
| Issuance of common stock related to employee stock purchase plan, shares |
|
|
|
208,030
|
|
|
|
|
|
|
|
| Issuance of common stock, net of offering costs |
|
$ 1,651,355
|
|
|
$ 1
|
|
|
$ 1,651,354
|
|
|
|
| Issuance of common stock upon offering, net of offering costs, shares |
|
|
|
|
12,147,887
|
|
|
|
|
|
|
| Exercise of warrants |
348
|
|
|
|
|
|
348
|
|
|
|
|
| Exercise of warrants, shares |
|
|
|
2,332
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
67,000
|
|
|
|
|
|
67,000
|
|
|
|
|
| Foreign currency translation adjustment |
(93)
|
|
|
|
|
|
|
|
|
(93)
|
|
| Net unrealized gain (loss) on marketable securities |
(5,235)
|
|
|
|
|
|
|
|
|
(5,235)
|
|
| Net Income (Loss) |
(644,371)
|
|
|
|
|
|
|
|
|
|
(644,371)
|
| Ending balance at Jun. 30, 2026 |
$ 2,606,238
|
|
|
$ 21
|
|
|
$ 6,579,456
|
|
|
$ (5,950)
|
$ (3,967,289)
|
| Ending balance, shares at Jun. 30, 2026 |
|
|
|
214,242,688
|
|
|
|
|
|
|
|